Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Biliary Tract Cancer, Molecular Pathology

Jean-Charles Nault

MD, PhD

🏢Hopital Jean Verdier🌐France

Professor of Hepatology and Oncology

38
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jean-Charles Nault at Hopital Jean Verdier is a French expert in hepatobiliary malignancies with contributions to molecular pathology and targeted therapy in biliary tract cancers. His research has contributed to the molecular characterization of biliary tract tumors within European PRODIGE network trials. He has been involved in evaluating KRAS G12C inhibitors in cholangiocarcinoma and other GI malignancies. His work on the genomic landscape of French and European BTC patient cohorts has contributed to the body of knowledge on molecular drivers in cholangiocarcinoma.

Share:

🧪Research Fields 研究领域

cholangiocarcinoma molecular pathology France
biliary tract cancer European research
KRAS G12C BTC
biliary cancer next-generation sequencing
French biliary oncology PRODIGE

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jean-Charles Nault 的研究动态

Follow Jean-Charles Nault's research updates

留下邮箱,当我们发布与 Jean-Charles Nault(Hopital Jean Verdier)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment